World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
40674
World Ranking
12472
National Ranking
6389

Overview

George Wilding is affiliated with the University of Wisconsin-Madison in the United States. Their research primarily spans the field of medicine, with a focus on pulmonary and respiratory medicine, radiology, nuclear medicine and imaging, cancer research, artificial intelligence, and molecular biology.

The scientist's work revolves around several main topics, including prostate cancer treatment and research, radiomics and machine learning in medical imaging, AI in cancer detection, advanced breast cancer therapies, breast cancer treatment studies, cancer related to hypoxia and metabolism, as well as cancer involving lipids and metabolism.

Among the recent papers authored or co-authored by George Wilding are:

  • Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma, 2023, published in Journal of Clinical Oncology
  • Prostate cancer cells survive anti-androgen and mitochondrial metabolic inhibitors by modulating glycolysis and mitochondrial metabolic activities, 2021, published in The Prostate
  • A Novel Artificial Intelligence-Powered Method for Prediction of Early Recurrence of Prostate Cancer After Prostatectomy and Cancer Drivers, 2022, published in JCO Clinical Cancer Informatics
  • Predicting Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy Using a Deep Convolutional Neural Network-Based Artificial Intelligence Tool, 2023, published in JCO Clinical Cancer Informatics
  • Mediator kinase inhibition reverses castration resistance of advanced prostate cancer, 2024, published in Journal of Clinical Investigation

Frequent co-authors in George Wilding's publications include:

  • Parag Jain
  • Hirak S. Basu
  • Muhammad Hassan
  • Peter S. Nelson
  • Howard I. Scher

Major venues where George Wilding's research has been published include:

  • The Prostate
  • Journal of Clinical Oncology
  • Cancer Research
  • The Journal of Urology
  • JCO Clinical Cancer Informatics

Best Publications

  • Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

    Robert J. Motzer;Thomas E. Hutson;Piotr Tomczak;M. Dror Michaelson

  • Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma

    Robert J. Motzer;M. Dror Michaelson;Bruce G. Redman;Gary R. Hudes

  • Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.

    Howard I. Scher;Susan Halabi;Ian Tannock;Michael Morris

  • Sunitinib in Patients With Metastatic Renal Cell Carcinoma

    Robert J. Motzer;Brian I. Rini;Brian I. Rini;Ronald M. Bukowski;Brendan D. Curti

  • Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.

    E M Messing;J Manola;M Sarosdy;G Wilding

  • Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    Howard I. Scher;Michael J. Morris;Walter M. Stadler;Celestia Higano

  • Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group

    Glenn J. Bubley;Michael Carducci;William Dahut;Nancy Dawson

  • Bilateral orchiectomy with or without flutamide for metastatic prostate cancer

    Mario A. Eisenberger;Brent A. Blumenstein;E. David Crawford;Gary Miller

  • Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy

    Edward M Messing;Judith Manola;Jorge Yao;Maureen Kiernan

  • Therapy-Induced Senescence in Cancer

    Jonathan A. Ewald;Joshua A. Desotelle;George Wilding;David F. Jarrard

  • Phase I Trial of the Oral Antiangiogenesis Agent AG-013736 in Patients With Advanced Solid Tumors: Pharmacokinetic and Clinical Results

    Hope S. Rugo;Roy S. Herbst;Glenn Liu;John W. Park

  • Adjuvant Sunitinib or Sorafenib for High-Risk, Non-Metastatic Renal-Cell Carcinoma (ECOG-ACRIN E2805): A Double-Blind, Placebo-Controlled, Randomised, Phase 3 Trial

    Naomi B. Haas;Judith Manola;Robert G. Uzzo;Keith T. Flaherty

  • Intermittent versus continuous androgen deprivation in prostate cancer.

    Maha Hussain;Catherine M. Tangen;Donna L. Berry;Celestia S. Higano

  • The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial

    Shahneen K Sandhu;Shahneen K Sandhu;William R Schelman;George Wilding;Victor Moreno

  • DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water.

    Randall Rage;Jacque Mitchen;George Wilding

  • Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study.

    Olivier Rixe;Ronald M Bukowski;M Dror Michaelson;George Wilding

  • Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma

    Brian I. Rini;George Wilding;Gary Hudes;Walter M. Stadler

  • Prooxidant-Antioxidant Shift Induced by Androgen Treatment of Human Prostate Carcinoma Cells

    Maureen O. Ripple;William F. Henry;Randall P. Rago;Randall P. Rago;George Wilding

  • Absolute Prostate-Specific Antigen Value After Androgen Deprivation Is a Strong Independent Predictor of Survival in New Metastatic Prostate Cancer: Data From Southwest Oncology Group Trial 9346 (INT-0162)

    Maha Hussain;Catherine M. Tangen;Celestia Higano;Paul F. Schelhammer

  • Phase III Study of Interferon Alfa-NL as Adjuvant Treatment for Resectable Renal Cell Carcinoma: An Eastern Cooperative Oncology Group/Intergroup Trial

    Edward M. Messing;Judith Manola;George Wilding;Kathleen Propert

Frequent Co-Authors

Michael A. Carducci
Michael A. Carducci Johns Hopkins University
Eric J. Small
Eric J. Small University of California, San Francisco
Edward M. Messing
Edward M. Messing University of Rochester Medical Center
Robert J. Motzer
Robert J. Motzer Memorial Sloan Kettering Cancer Center
Jordan Berlin
Jordan Berlin Vanderbilt University Medical Center
Maha Hussain
Maha Hussain Northwestern University
Michael J. Morris
Michael J. Morris Memorial Sloan Kettering Cancer Center
Mario A. Eisenberger
Mario A. Eisenberger Johns Hopkins University
E. David Crawford
E. David Crawford University of California, San Diego
Celestia S. Higano
Celestia S. Higano University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Choosing to study Medicine in the USA opens up a variety of online degrees and alternative healthcare career pathways. If you have a non-nursing background but wish to transition quickly into the nursing field, you may consider direct entry msn programs for non-nursing majors online. These programs are designed to help graduates pivot into advanced nursing roles with less time spent in school.

For those looking for quicker entry or a smoother admission process, researching the easiest rn program can help you find nursing schools with higher acceptance rates and flexible requirements. Additionally, some prospective nurses seek options like a nursing school that does not require teas test, eliminating certain entrance exams to streamline the admission process.

Interested in administrative healthcare roles? There are reputable online medical coding classes with financial aid that make it easier to start a career in medical billing and coding. These flexible online programs can provide a pathway to in-demand healthcare support positions, often with accessible admission requirements and financial support options.

Best Scientists Citing George Wilding

Trending Scientists

Recently Published Articles